Roy F. Chemaly

Statistics

Publications

163

Citations

17K

H-Index

Active since

1988

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Baylor College of Medicine

Memorial Sloan Kettering Cancer Center

Fred Hutch Cancer Center

The University of Texas Health Science Center at Houston

Roy F. Chemaly is an author at The University of Texas MD Anderson Cancer Center specializing in infectious diseases, life sciences, and antiviral therapy.

ORCID

Publications per year

1988–2025

163

Publications

163

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

Vancheswaran Gopalakrishnan, Luigi Nezi, Alexandre Reuben et al. · Science · 2017 · 4.7K citations · Full text

Life Sciences, Immunology, Oncology +17

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

Francisco M. Marty, Per Ljungman, Roy F. Chemaly et al. · New England Journal of Medicine · 2017 · 1.2K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003).

Georgios Chamilos, Mario A. Luna, Russell E. Lewis et al. · PubMed · 2006 · 479 citations

Medicine, Infectious Diseases, Pathology +15

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

Roy F. Chemaly, Andrew J. Ullmann, Susanne Stoelben et al. · New England Journal of Medicine · 2014 · 371 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

Akshay Sharma, Neel S. Bhatt, Andrew St. Martin et al. · The Lancet Haematology · 2021 · 360 citations · Full text

Medicine, Hematology, Infectious Diseases +15

1–5 of 163